James Simsarian

685 total citations
13 papers, 316 citations indexed

About

James Simsarian is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, James Simsarian has authored 13 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Immunology. Recurrent topics in James Simsarian's work include Multiple Sclerosis Research Studies (8 papers), Viral Infections and Immunology Research (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). James Simsarian is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Viral Infections and Immunology Research (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). James Simsarian collaborates with scholars based in United States, United Kingdom and Russia. James Simsarian's co-authors include Gavin Giovannoni, Gabriel Pardo, Bettina Stubinski, Per Soelberg Sørensen, О. Л. Барбараш, Carol Saunders, Luanne M. Metz, John King, Michelle Smith and John L. Decker and has published in prestigious journals such as Multiple Sclerosis Journal, Clinical Therapeutics and Value in Health.

In The Last Decade

James Simsarian

12 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Simsarian United States	9	185	87	68	62	59	13	316
C. A. Vedeler Norway	11	229 1.2×	72 0.8×	79 1.2×	72 1.2×	108 1.8×	13	442
Victoria Fernández Spain	13	302 1.6×	91 1.0×	93 1.4×	118 1.9×	82 1.4×	40	483
Amy Perrin Ross United States	12	265 1.4×	61 0.7×	66 1.0×	59 1.0×	76 1.3×	35	425
DS Goodin United States	6	409 2.2×	127 1.5×	94 1.4×	95 1.5×	132 2.2×	9	482
B. Runmarker Sweden	8	419 2.3×	137 1.6×	196 2.9×	65 1.0×	104 1.8×	9	553
Howard Rossman United States	7	336 1.8×	54 0.6×	66 1.0×	84 1.4×	111 1.9×	9	403
Gary L. Klipple United States	12	69 0.4×	125 1.4×	130 1.9×	30 0.5×	18 0.3×	15	390
Claire Hara-Cleaver United States	8	376 2.0×	83 1.0×	31 0.5×	101 1.6×	99 1.7×	11	436
Christoph Thalheim United Kingdom	7	420 2.3×	76 0.9×	26 0.4×	59 1.0×	92 1.6×	8	504
Olivier Heinzlef France	10	383 2.1×	59 0.7×	41 0.6×	110 1.8×	205 3.5×	25	604

Countries citing papers authored by James Simsarian

Since Specialization

Citations

This map shows the geographic impact of James Simsarian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Simsarian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Simsarian more than expected).

Fields of papers citing papers by James Simsarian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Simsarian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Simsarian. The network helps show where James Simsarian may publish in the future.

Co-authorship network of co-authors of James Simsarian

This figure shows the co-authorship network connecting the top 25 collaborators of James Simsarian. A scholar is included among the top collaborators of James Simsarian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Simsarian. James Simsarian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Tyry, Tuula, et al.. (2015). Care Partners and Multiple Sclerosis. International Journal of MS Care. 17(6). 253–260. 27 indexed citations

Simsarian, James, Carol Saunders, & Michelle Smith. (2011). Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial. Drug Design Development and Therapy. 5. 381–381. 27 indexed citations

Simsarian, James, О. Л. Барбараш, Gavin Giovannoni, et al.. (2008). Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif (R) new formulation) in a phase IIIb study in patients with relapsing multiple sclerosis: 96-week results. 38 indexed citations

Giovannoni, Gavin, О. Л. Барбараш, Jenny King, et al.. (2008). Immunogenicity of Rebif (R) New Formulation (interferon beta-1a) in patients with relapsing multiple sclerosis: results from a phase IIIb study. 3 indexed citations

Giovannoni, Gavin, О. Л. Барбараш, John King, et al.. (2008). Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results. Multiple Sclerosis Journal. 15(2). 219–228. 54 indexed citations

Wilken, Jeffrey, Mitchell T. Wallin, Catherine H. Rogers, et al.. (2008). Treatment of Multiple Sclerosis–Related Cognitive Problems With Adjunctive Modafinil. International Journal of MS Care. 10(1). 1–10. 11 indexed citations

Giovannoni, Gavin, et al.. (2007). The Rebif® New Formulation Story. Drugs in R&D. 8(6). 335–348. 30 indexed citations

Giovannoni, Gavin, О. Л. Барбараш, Florence Casset‐Semanaz, et al.. (2007). Immunogenicity and tolerability of an investigational formulation of interferon-β1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis. Clinical Therapeutics. 29(6). 1128–1145. 34 indexed citations

Simsarian, James, A AL-Sabbagh, Robert M. Bennett, Bettina Stubinski, & Gabriel Pardo. (2007). PND2 SAFETY AND IMMUNOGENICITY OF REBIF® NEW FORMULATION (RNF) A NEW SUBCUTANEOUS FORMULATION OF INTERFERON BETA-1A 44 MCG THREE TIMES WEEKLY: 1-YEAR RESULTS OF A PHASE IIIB STUDY IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS. Value in Health. 10(3). A87–A87. 1 indexed citations

10.

Wilken, Jeffrey, Robert L Kane, Mitchell T. Wallin, et al.. (2003). The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 9(2). 119–127. 57 indexed citations

11.

Simsarian, James, et al.. (1973). Virologic Studies on Rheumatoid Arthritis. Arthritis & Rheumatism. 16(4). 446–454. 32 indexed citations

12.

Simsarian, James. (1965). Interim Arrangements for a Global Commercial Communications Satellite System. American Journal of International Law. 59(2). 344–351. 1 indexed citations

13.

Simsarian, James. (1951). Draft International Covenant on Human Rights Revised at 1950 Session of the United Nations Commission on Human Rights. American Journal of International Law. 45(1). 170–177. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact